Appointment
Eisai Inc. Deepens Its Commitment to Alzheimer's Disease with Key Executive Appointments
Eisai
PR-M05-19-NI-015May 06, 2019
Alzheimer's Disease
First Drug Candidate From Eisai-UCL Research Collaboration To Enter Alzheimer's Disease Clinical Trials
Eisai
PR-M12-18-NI-037Dec 12, 2018
Epilepsy
New Analyses Evaluate Long-Term Convulsive Seizure Freedom Rates With Use Of Adjunctive FYCOMPA® (perampanel) CIII In Adult Patients Presented at Annual Meeting of the AES
Eisai
PR-M12-18-NI-015Dec 05, 2018
Clinical Data
Eisai Inc. Announces Positive Topline Results from CAMELLIA-TIMI 61, a Large-Scale Cardiovascular Outcome Trial for the Anti-Obesity Agent BELVIQ®
Eisai
PR-M07-18-NI-056Jul 18, 2018